ARTICLE | Company News
Bolder BioTechnology other research news
January 17, 2005 8:00 AM UTC
Bolder announced that National Institute of Allergy and Infectious Diseases (NIAID) awarded a $303,204 Phase I SBIR grant to be used to optimize the manufacturing process and perform preclinical toxic...